Mirae Asset Global Investments’s Maravai LifeSciences MRVI Stock Holding History

Mirae Asset Global Investments’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.2K	Sell	6,597 -1,038	-14%	-$4.48K	﹤0.01%	1386
2026 Q1	$21.6K	Buy	7,635 +588	+8%	+$1.99K	﹤0.01%	1422
2025 Q4	$22.9K	Buy	7,047 +1,454	+26%	+$4.89K	﹤0.01%	1522
2025 Q3	$16.1K	Buy	5,593 +31	+0.6%	+$79	﹤0.01%	1517
2025 Q2	$13.4K	Buy	5,562 +874	+19%	+$1.84K	﹤0.01%	1450
2025 Q1	$11.1K	Sell	4,688 -39	-0.8%	-$154	﹤0.01%	1456
2024 Q4	$26K	Sell	4,727 -393	-8%	-$2.53K	﹤0.01%	1386
2024 Q3	$43.1K	Buy	5,120 +1,154	+29%	+$9.98K	﹤0.01%	1330
2024 Q2	$28.1K	Buy	+3,966	New	+$34.2K	﹤0.01%	1341

Other funds holding MRVI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

DRP

Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Mirae Asset Global Investments's MRVI Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Maravai LifeSciences (MRVI) stake by 14% in Q2 2026, selling an estimated $4.48K and leaving 6,597 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Mirae Asset Global Investments first reported a position in MRVI in Q2 2024 and has held it in 9 quarters since. The position peaked at $43.1K in Q3 2024. 52 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Mirae Asset Global Investments held 6,597 shares of Maravai LifeSciences worth $41.2K as of Q2 2026.
Mirae Asset Global Investments sold 1,038 Maravai LifeSciences shares in Q2 2026, an estimated $4.48K.
Maravai LifeSciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1386 holding.
Mirae Asset Global Investments first reported a position in Maravai LifeSciences in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global Investments's Maravai LifeSciences position peaked at $43.1K in Q3 2024.
52 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.